Issue 42 - The Cancer Letter

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Skip Trump builds a cancer center by the Beltway

Trump's plans for Inova reach across the Washington Beltway, through Virginia—and beyond

CMS plan to slash $1.6 billion from 340B program will reduce discounts on cancer drugs

In Brief

WUSTL's DiPersio receives $6 million for leukemia research

Hopkins researchers launch interdisciplinary effort for breast cancer

Gad Getz, Chuan He, and Aviv Regev win Paul Marks Prize

Neuroblastoma foundation awards grant to Harvard's Malgorzata Krajewska

Sanford Health wins ACCC David King Award

Ohio State receives Press Ganey Guardian of Excellence Award

NCI grant will support UA research in “lung cancer stigma”

NCCN publishes guidelines for cancer treatment in sub-Saharan Africa

Drugs & Targets

Alecensa gets FDA approval for ALK-positive metastatic NSCLC

FDA approves first treatment for Erdheim-Chester Disease

FDA approves Adcetris for cutaneous anaplastic large cell lymphoma

Seattle Genetics submits sBLA for Adcetris in Hodgkin lymphoma

Recent Issues

Renew today!

Subscriber content